2010 NCVH Accreditation

Course Description

Overview
This multidisciplinary international conference offers the practicing physician, podiatrist, resident, nurse and other allied health professionals, a comprehensive overview of the diagnosis and management of cardiovascular disease and critical limb ischemia (CLI) with emphasis on peripheral vascular disease (PVD), coronary artery disease (CAD), limb salvage, and the diabetic foot and wound care. A multidisciplinary team approach will be utilized to highlight the recent advancements that have been made in the field of cardiovascular medicine and CLI with an emphasis on the high association of PVD and CAD. In addition to didactic lectures and workshops, the internationally acclaimed conference faculty will review concepts, as well as cutting edge non-surgical and surgical revascularization techniques for limb salvage.

Target Audience
Cardiologists * Cardiothoracic, Endovascular, Vascular & General Surgeons * Diabetes & Wound Care Specialists * Emergency Medical Technicians * Endocrinologists * Family Practitioners * Healthcare Administrators * Internists * Interventional Radiologists * Nurses/Advanced Practice Registered Nurses * Osteopaths  * Paramedics * Physical Medicine and Rehabilitation * Physical Therapists * Physician Assistants * Podiatrists * Radiologic Technologists * Residents * Vascular Medicine Specialists

Educational Objectives
Upon completion of this offering, the participant should be able to:

• Assess CLI and Cardiovascular disease risk factors with particular regard to diabetes pathogenesis, classification, and differential diagnoses of peripheral vascular disease and CLI.
• Utilize various testing modalities to aid in the diagnosis of foot ulcerations and CLI.
• Assess pharmacologic agents and local treatments in the care of the non-healing foot wound.
• Assess non-surgical intervention (balloon angioplasty and stenting, drug-eluting stents, excimer laser, cryotherapy, and plaque excision) and the surgical options available to revascularize the ischemic foot.
• Assess new non-surgical and surgical options emerging in treatment of cardiovascular disease and CLI.
• Integrate the Diabetes Update - newest treatment for diabetes and its complications.
• Integrate the CHF Update - Role of new therapies in treatment of CHF.
• Assess new aggressive treatments for stroke - carotid stenting.
• Review primary and secondary prevention update - cholesterol – exercise.
• Integrate creative surgical, non-surgical, and local therapies for limb salvage.
• Assess the newest medical, pharmacological, surgical and device treatments for coronary artery disease.
  

*** ADVISORY *** - The Attendance Certificates for CME credit or contact hours will be issued ON SITE at the conference. There will be a $50.00 fee for duplicate certificates issued after the conference.

ACCREDITATION

CME: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Cardiovascular Institute of the South (CIS) and South Louisiana Clinical Research Foundation. CIS is accredited by the ACCME to provide continuing medical education for physicians.

CPME: Cardiovascular Institute of the South (CIS) is approved by the Council on Podiatric Medical Education as a sponsor of continuing education in podiatric medicine.

Allied Health Professionals will receive a certificate of participation.

CNE: Provider to be announced at a later date.

AACN: Provider to be announced at a later date.

ASRT: Details to be announced at a later date.

DISCLOSURE
It is the policy of Cardiovascular Institute of the South, APMC (CIS) to ensure balance, independence, objectivity, and scientific rigor in all its sponsored educational programs. Therefore, CIS shall identify and resolve conflicts of interest by requiring everyone who is in a position to control the content of the educational activity to disclose all relevant financial relationships with commercial supporters. Disclosure will include:
1) any affiliation or financial interest that may affect the speaker's presentation(s),
2) whether the speaker will discuss an investigational product or the off-label use of a commercial product,
3) that the recommendations involving clinical medicine are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients, and
4) that all scientific research referred to, reported or used in support or justification of a patient care recommendation conforms to the generally accepted standards of experimental design, data collection, and analysis.

The intent of this policy is not to prevent a speaker with an affiliation or financial interest from participating in the planning or implementation of the CME activity, but rather to resolve any conflict of interest prior to developing the education activity by:
1) identifying the relationship,
2) instructing speakers to base recommendations for clinical medicine on the best available evidence, and if necessary
3) submitting content to peer review during development to ensure it is clinically valid, based on generally accepted scientific research, and aligned with the interests of the public.

Complete disclosure information will be included in the New Cardiovascular Horizons (NCVH) syllabus.

COMMERCIAL
This conference is being funded by educational grants from commercial organizations. A complete list will be published in the course notebook.

EXHIBITS
Several medical device, service and pharmaceutical companies will display their products in the Exhibit Hall.

AMERICANS WITH DISABILITIES
In compliance with the Americans with Disabilities Act, NCVH will make every effort to accommodate persons with disabilities at the conference. If special assistance is required, please indicate your needs by calling the NCVH office at (337) 993-7920.

NOTE: This program schedule is accurate as of printing time. We reserve the right to make changes; any such changes will be announced at the meeting.